Medications

Added benefit of lisdexamfetamine is not proven

Lisdexamfetamine dimesylate (trade name: Elvanse) has been approved in Germany since March 2013 as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (ADHD) in children aged 6 years and ...

Cardiology

Guideline-directed medical tx adherence low post CABG

(HealthDay)—Compliance with guideline-directed medical therapy (GDMT) is low, and remains higher in percutaneous coronary intervention (PCI) than in coronary artery bypass grafting (CABG), according to a review published ...

Health

USPSTF urges primary care docs to ask adults about drug use

(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends that primary care clinicians ask adults about drug use and connect them to services for treatment and appropriate care. These recommendations form ...

page 12 from 13